Active ingredientPranlukastCat. No. P-P168-001CAS 103177-37-3Family · Pharmaceutical analytical standards
Pranlukast
A cysteinyl leukotriene receptor antagonist, launched in Japan in 1995 for bronchial asthma and later also approved for allergic rhinitis. This family brings together the active ingredient, labelled standards, nitrosamines and other impurities.
Did you know?The name leukotriene was coined in 1979 by the Swede Bengt Samuelsson: it joins 'leukocyte', the white blood cell, and 'triene', for the molecule's three conjugated double bonds.
Go to the active ingredient →Active ingredientPranlukastCat. No. P-P168-001CAS 103177-37-3
Isotopically labelledPranlukast-d4Cat. No. P-P168-002CAS 2713172-43-9
NitrosamineN-Nitroso PranlukastCat. No. P-P168-003
ImpurityPranlukast Chromene Carboxamide ImpurityCat. No. P-P168-004CAS 136450-10-7
ImpurityPranlukast Chromene Carboxylic Acid ImpurityCat. No. P-P168-005CAS 211116-98-2
ImpurityPranlukast Impurity 1Cat. No. P-P168-006
ImpurityPranlukast Impurity 2Cat. No. P-P168-007
ImpurityPranlukast Impurity 3Cat. No. P-P168-008
ImpurityPranlukast Impurity 4Cat. No. P-P168-009No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.